The anti-obesity potential of sigmoidin A

Pharmaceutical Biology

Volumn 50, Issue 12, 2012, Pages 1519-1522

  Habtemariam, Solomon ^a  

^a UNIVERSITY OF GREENWICH   (United Kingdom)

Author keywords

glucosidase; Eriodictyol; Erythrina abyssinica; Fabaceae; Obesity; Pancreatic lipase; Prenylated flavonoids; Sigmoidin A

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE; ERIODICTYOL; FLAVONOID; SIGMOIDIN A; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; ENZYME INHIBITION; ERYTHRINA; ERYTHRINA ABYSSINICA; IC 50; IN VITRO STUDY; PRENYLATION;

ACARBOSE; ALPHA-GLUCOSIDASES; ANTI-OBESITY AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ERYTHRINA; FLAVANONES; FLAVONOIDS; LACTONES; LIPASE; MOLECULAR STRUCTURE; PLANT BARK; PLANT EXTRACTS; PLANTS, MEDICINAL; PRENYLATION; STRUCTURE-ACTIVITY RELATIONSHIP;

ERYTHRINA ABYSSINICA; FABACEAE;

EID: 84869452401     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2012.688838     Document Type: Article

References (33)

1. Abubakari AR, Bhopal RS. (2008). Systematic review on the prevalence of diabetes, overweight/obesity and physical inactivity in Ghanaians and Nigerians. Public Health, 122, 173-182.
2. Ballinger A, Peikin SR. (2002). Orlistat: Its current status as an antiobesity drug. Eur J Pharmacol, 440, 109-117. (Pubitemid 34458018)
3. CDC (Centres for disease control and prevention) (2012). U.S. Obesity Trends http://www.cdc.gov/obesity/data/trends.HTML. Accessed on 6 April 2012.
4. Chen Y-H, Chang F-R, Lin Y-J, Hsieh P-W, Wu M-J, Wu Y-C. (2008). Identification of antioxidants from rhizome of Davallia solida. Food Chem 107, 684-691. (Pubitemid 350116372)
5. Cui L, Ndinteh DT, Na M, Thuong PT, Silike-Muruumu J, Njamen D, Mbafor JT, Fomum ZT, Ahn JS, Oh WK. (2007). Isoprenylated flavonoids from the stem bark of Erythrina abyssinica. J Nat Prod, 70, 1039-1042. (Pubitemid 47056124)
6. Diabetes UK (2012). Diabetes and obesity. Available at: http://www. diabetes.co.uk/diabetes-and-obesity.html. Accessed on 6 April 2012.
7. Fomum ZT, Ayafor JF, Mbafor JT. (1983). Erythrina studies: Part 1. Novel antibacterial flavanones from Erythina sigmoidea. Tet Lett, 24, 4127-4130. (Pubitemid 13019796)
8. Galati G, Sabzevari O, Wilson JX, O'Brien PJ. (2002). Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics. Toxicology, 177, 91-104. (Pubitemid 34786247)
9. Golay A, Ybarra J. (2005). Link between obesity and type 2 diabetes. Best Pract Res Clin Endocrinol Metab, 19, 649-663. (Pubitemid 41819224)
10. Habtemariam S. (2011). A-glucosidase inhibitory activity of kaempferol-3-O-rutinoside. Nat Prod Commun, 6, 201-203.
11. Habtemariam S, Dagne E. (2010). Comparative antioxidant, prooxidant and cytotoxic activity of sigmoidin A and eriodictyol. Planta Med, 76, 589-594.
12. Haslam D. (2010). Obesity and diabetes: The links and common approaches. Prim Care Diabetes, 4, 105-112.
13. Ichimaru M, Moriyasu M, Nishiyama Y, Kato A. (1996). Structural elucidation of new flavanones isolated from Erythrina abyssinica. J Nat Prod, 59, 111-116.
14. Lee ER, Kim JH, Choi HY, Jeon K, Cho SG. (2011). Cytoprotective effect of eriodictyol in UV-irradiated keratinocytes via phosphatasedependent modulation of both the p38 MAPK and Akt signaling pathways. Cell Physiol Biochem, 27, 513-524.
15. Lee JK. (2011). Anti-inflammatory effects of eriodictyol in lipopolysaccharide-stimulated raw 264.7 murine macrophages. Arch Pharm Res, 34, 671-679.
16. Njamen D, Mbafor JT, Fomum ZT, Kamanyi A, Mbanya JC, Recio MC, Giner RM, Máñez S, Ríos JL. (2004). Anti-inflammatory activities of two flavanones, sigmoidin A and sigmoidin B, from Erythrina sigmoidea. Planta Med, 70, 104-107. (Pubitemid 38299769)
17. Narváez-Mastache JM, Novillo F, Delgado G. (2008). Antioxidant arylprenylcoumarin, flavan-3-ols and flavonoids from Eysenhardtia subcoriacea. Phytochemistry, 69, 451-456.
18. Ogata S, Miyake Y, Yamamoto K, Okumura K, Taguchi H. (2000). Apoptosis induced by the flavonoid from lemon fruit (Citrus limon BURM. f.) and its metabolites in HL-60 cells. Biosci Biotechnol Biochem, 64, 1075-1078.
19. Padwal RS, Majumdar SR. (2007). Drug treatments for obesity: Orlistat, sibutramine, and rimonabant. Lancet, 369, 71-77. (Pubitemid 46027230)
20. PHAC (Public Health Agency of Canada) (2012). Obesity in Canada. Available at: http://www.phac-aspc.gc.ca/hp-ps/hl-mvs/oic-oac/index-eng.php. Accessed on 6 April 2012.
21. Polednak AP. (2003). Trends in incidence rates for obesity-associated cancers in the US. Cancer Detect Prev, 27, 415-421. (Pubitemid 37506954)
22. Rossato MF, Trevisan G, Walker CI, Klafke JZ, de Oliveira AP, Villarinho JG, Zanon RB, Royes LF, Athayde ML, Gomez MV, Ferreira J. (2011). Eriodictyol: A flavonoid antagonist of the TRPV1 receptor with antioxidant activity. Biochem Pharmacol, 81, 544-551.
23. Roselli M, Lentini G, Habtemariam S. (2011). Phytochemical, antioxidant and anti-α-glucosidase activity evaluations of Bergenia cordifolia. Phytother Res. DOI: 10.1002/ptr.3655.
24. Schoeller DA. (2008). Insights into energy balance from doubly labeled water. Int J Obes (Lond), 32 Suppl 7, S72-S75.
25. Tsimogiannis DI, Oreopoulou V. (2004). Free radical scavenging and antioxidant activity of 5,7,3′,4′-hydroxy-substituted flavonoids. Innov Food Sci Emerg Technol 5, 523-528.
26. Tsimogiannis DI, Oreopoulou V. (2006). The contribution of flavonoid C-ring on the DPPH free radical scavenging efficiency. A kinetic approach for the 3′,4′-hydroxy substituted members. Innov Food Sci Emerg Technol 7, 140-146. (Pubitemid 44294639)
27. Visscher TL, Seidell JC. (2001). The public health impact of obesity. Annu Rev Public Health, 22, 355-375. (Pubitemid 32452512)
28. WHO (2012). Obesity: Facts and figures. Available at: http://www. euro.who.int/en/what-we-do/health-topics/noncommunicablediseases/obesity/ facts-and-figures. Accessed on 6 April 2012.
29. Yenesew A, Induli M, Derese S, Midiwo JO, Heydenreich M, Peter MG, Akala H, Wangui J, Liyala P, Waters NC. (2004). Antiplasmodial flavonoids from the stem bark of Erythrina abyssinica. Phytochemistry, 65, 3029-3032. (Pubitemid 39422299)
30. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY. (2006). Epidemic obesity and type 2 diabetes in Asia. Lancet, 368, 1681-1688. (Pubitemid 46048556)
31. You Q, Chen F, Wang X, Jiang Y, Lin S. (2012). Anti-diabetic activities of phenolic compounds in muscadine against alpha-glucosidase and pancreatic lipase. LWT-Food Sci Technol, 46, 164-168.
32. Zalesin KC, Franklin BA, Miller WM, Peterson ED, McCullough PA. (2011). Impact of obesity on cardiovascular disease. Med Clin North Am, 95, 919-937.
33. Zhang L, Li J, Hogan S, Chung H, Welbaum GE, Zhou K. (2010). Inhibitory effect of raspberries on starch digestive enzyme and their antioxidant properties and phenolic composition. Food Chem, 119, 592-599.